Logo image of DLX.DE

DELIGNIT AG (DLX.DE) Stock Fundamental Analysis

Europe - FRA:DLX - DE000A0MZ4B0 - Common Stock

2.28 EUR
0 (0%)
Last: 9/30/2025, 7:00:00 PM
Fundamental Rating

5

Overall DLX gets a fundamental rating of 5 out of 10. We evaluated DLX against 11 industry peers in the Paper & Forest Products industry. DLX has an average financial health and profitability rating. DLX has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

DLX had positive earnings in the past year.
Each year in the past 5 years DLX has been profitable.
DLX had a positive operating cash flow in 4 of the past 5 years.
DLX.DE Yearly Net Income VS EBIT VS OCF VS FCFDLX.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M 6M

1.2 Ratios

DLX's Return On Assets of 1.77% is in line compared to the rest of the industry. DLX outperforms 54.55% of its industry peers.
Looking at the Return On Equity, with a value of 2.33%, DLX is in line with its industry, outperforming 54.55% of the companies in the same industry.
DLX has a worse Return On Invested Capital (2.11%) than 63.64% of its industry peers.
DLX had an Average Return On Invested Capital over the past 3 years of 6.49%. This is in line with the industry average of 6.20%.
The 3 year average ROIC (6.49%) for DLX is well above the current ROIC(2.11%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 1.77%
ROE 2.33%
ROIC 2.11%
ROA(3y)5.21%
ROA(5y)5.41%
ROE(3y)7.38%
ROE(5y)8.31%
ROIC(3y)6.49%
ROIC(5y)7.02%
DLX.DE Yearly ROA, ROE, ROICDLX.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

The Profit Margin of DLX (1.39%) is comparable to the rest of the industry.
In the last couple of years the Profit Margin of DLX has declined.
With a Operating Margin value of 1.99%, DLX is not doing good in the industry: 72.73% of the companies in the same industry are doing better.
DLX's Operating Margin has declined in the last couple of years.
With an excellent Gross Margin value of 43.73%, DLX belongs to the best of the industry, outperforming 81.82% of the companies in the same industry.
DLX's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 1.99%
PM (TTM) 1.39%
GM 43.73%
OM growth 3Y-21.75%
OM growth 5Y-7.53%
PM growth 3Y-20.84%
PM growth 5Y-4.84%
GM growth 3Y1.28%
GM growth 5Y2.22%
DLX.DE Yearly Profit, Operating, Gross MarginsDLX.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

More info and screens

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so DLX is destroying value.
Compared to 1 year ago, DLX has about the same amount of shares outstanding.
Compared to 5 years ago, DLX has more shares outstanding
Compared to 1 year ago, DLX has an improved debt to assets ratio.
DLX.DE Yearly Shares OutstandingDLX.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
DLX.DE Yearly Total Debt VS Total AssetsDLX.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

An Altman-Z score of 3.92 indicates that DLX is not in any danger for bankruptcy at the moment.
DLX has a better Altman-Z score (3.92) than 100.00% of its industry peers.
A Debt/Equity ratio of 0.03 indicates that DLX is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.03, DLX belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z 3.92
ROIC/WACC0.29
WACC7.3%
DLX.DE Yearly LT Debt VS Equity VS FCFDLX.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M

2.3 Liquidity

DLX has a Current Ratio of 4.14. This indicates that DLX is financially healthy and has no problem in meeting its short term obligations.
DLX's Current ratio of 4.14 is amongst the best of the industry. DLX outperforms 100.00% of its industry peers.
DLX has a Quick Ratio of 1.86. This is a normal value and indicates that DLX is financially healthy and should not expect problems in meeting its short term obligations.
DLX's Quick ratio of 1.86 is amongst the best of the industry. DLX outperforms 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 4.14
Quick Ratio 1.86
DLX.DE Yearly Current Assets VS Current LiabilitesDLX.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

4

3. Growth

3.1 Past

The earnings per share for DLX have decreased strongly by -57.89% in the last year.
The Earnings Per Share has been decreasing by -7.22% on average over the past years.
The Revenue for DLX has decreased by -16.67% in the past year. This is quite bad
DLX shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.24% yearly.
EPS 1Y (TTM)-57.89%
EPS 3Y-24.93%
EPS 5Y-7.22%
EPS Q2Q%-33.33%
Revenue 1Y (TTM)-16.67%
Revenue growth 3Y-1.58%
Revenue growth 5Y0.24%
Sales Q2Q%-8.15%

3.2 Future

The Earnings Per Share is expected to grow by 41.22% on average over the next years. This is a very strong growth
DLX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.46% yearly.
EPS Next Y27.27%
EPS Next 2Y56.67%
EPS Next 3Y44.23%
EPS Next 5Y41.22%
Revenue Next Year1.47%
Revenue Next 2Y7.57%
Revenue Next 3Y8.48%
Revenue Next 5Y7.46%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
DLX.DE Yearly Revenue VS EstimatesDLX.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 20M 40M 60M 80M 100M
DLX.DE Yearly EPS VS EstimatesDLX.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0.2 0.4 0.6

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 28.50, which means the current valuation is very expensive for DLX.
The rest of the industry has a similar Price/Earnings ratio as DLX.
DLX's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.76.
A Price/Forward Earnings ratio of 8.36 indicates a reasonable valuation of DLX.
Compared to the rest of the industry, the Price/Forward Earnings ratio of DLX indicates a somewhat cheap valuation: DLX is cheaper than 72.73% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.18, DLX is valued rather cheaply.
Industry RankSector Rank
PE 28.5
Fwd PE 8.36
DLX.DE Price Earnings VS Forward Price EarningsDLX.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

DLX's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. DLX is cheaper than 81.82% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 4.72
DLX.DE Per share dataDLX.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

DLX's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
DLX's earnings are expected to grow with 44.23% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.04
PEG (5Y)N/A
EPS Next 2Y56.67%
EPS Next 3Y44.23%

More info and screens

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.08%, DLX has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 3.90, DLX has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.41, DLX has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.08%

5.2 History

On average, the dividend of DLX grows each year by 11.75%, which is quite nice.
Dividend Growth(5Y)11.75%
Div Incr Years0
Div Non Decr Years0
DLX.DE Yearly Dividends per shareDLX.DE Yearly Dividends per shareYearly Dividends per share 2019 2021 2023 2024 2025 0.02 0.04 0.06 0.08

5.3 Sustainability

DLX's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DPN/A
EPS Next 2Y56.67%
EPS Next 3Y44.23%
DLX.DE Yearly Income VS Free CF VS DividendDLX.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M

More info and screens

DELIGNIT AG

FRA:DLX (9/30/2025, 7:00:00 PM)

2.28

0 (0%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryPaper & Forest Products
Earnings (Last)08-26 2025-08-26
Earnings (Next)N/A N/A
Inst Owners69.37%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap23.35M
Analysts84
Price Target6.12 (168.42%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.08%
Yearly Dividend0.08
Dividend Growth(5Y)11.75%
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-13.67%
PT rev (3m)-13.67%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-33.33%
EPS NY rev (3m)-56.92%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-5.76%
Revenue NY rev (3m)-21.24%
Valuation
Industry RankSector Rank
PE 28.5
Fwd PE 8.36
P/S 0.38
P/FCF N/A
P/OCF N/A
P/B 0.63
P/tB 0.68
EV/EBITDA 4.72
EPS(TTM)0.08
EY3.51%
EPS(NY)0.27
Fwd EY11.96%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS6.07
BVpS3.62
TBVpS3.34
PEG (NY)1.04
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.77%
ROE 2.33%
ROCE 2.98%
ROIC 2.11%
ROICexc 2.64%
ROICexgc 2.9%
OM 1.99%
PM (TTM) 1.39%
GM 43.73%
FCFM N/A
ROA(3y)5.21%
ROA(5y)5.41%
ROE(3y)7.38%
ROE(5y)8.31%
ROIC(3y)6.49%
ROIC(5y)7.02%
ROICexc(3y)7.91%
ROICexc(5y)8.19%
ROICexgc(3y)8.82%
ROICexgc(5y)9.23%
ROCE(3y)9.19%
ROCE(5y)9.93%
ROICexcg growth 3Y-25.04%
ROICexcg growth 5Y-10.87%
ROICexc growth 3Y-24.73%
ROICexc growth 5Y-10.11%
OM growth 3Y-21.75%
OM growth 5Y-7.53%
PM growth 3Y-20.84%
PM growth 5Y-4.84%
GM growth 3Y1.28%
GM growth 5Y2.22%
F-ScoreN/A
Asset Turnover1.28
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA 0.32
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.14
Quick Ratio 1.86
Altman-Z 3.92
F-ScoreN/A
WACC7.3%
ROIC/WACC0.29
Cap/Depr(3y)125.11%
Cap/Depr(5y)92.99%
Cap/Sales(3y)3.97%
Cap/Sales(5y)3.03%
Profit Quality(3y)140.65%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-57.89%
EPS 3Y-24.93%
EPS 5Y-7.22%
EPS Q2Q%-33.33%
EPS Next Y27.27%
EPS Next 2Y56.67%
EPS Next 3Y44.23%
EPS Next 5Y41.22%
Revenue 1Y (TTM)-16.67%
Revenue growth 3Y-1.58%
Revenue growth 5Y0.24%
Sales Q2Q%-8.15%
Revenue Next Year1.47%
Revenue Next 2Y7.57%
Revenue Next 3Y8.48%
Revenue Next 5Y7.46%
EBIT growth 1Y-53.75%
EBIT growth 3Y-22.99%
EBIT growth 5Y-7.31%
EBIT Next Year160%
EBIT Next 3Y71%
EBIT Next 5Y54.93%
FCF growth 1Y-37.97%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-10.76%
OCF growth 3YN/A
OCF growth 5Y21.67%